CTC researchers and their collaborators have a strong record of published research in prestigious international journals. Recent journal articles are listed here.

Use the search link below to find specific articles, or articles by year, author, trial or group, back to 2005.

Search for articles


Agar Meera, Koh Eng-Siew, Gibbs Emma, Barnes ElizabethH, Hovey Elizabeth, Livingstone Ann, Sawkins Kate, Chye Richard, Lovell MelanieR, Clark Katherine, Vardy Janette, King Madeleine. Validating self-report and proxy reports of the Dexamethasone Symptom Questionnaire-Chronic for the evaluation of longer-term corticosteroid toxicity. Supportive Care in Cancer 2015; : 1-10.

Baker J., Janda M., Gebski V., Forder P., Hogg R., Manolitsas T., Obermair A. Lower preoperative quality of life increases postoperative risk of adverse events in women with endometrial cancer: results from the LACE trial. Gynecologic Oncology 2015;  137 (1): 102-5.

Basu A., Yu J. Y., Jenkins A. J., Nankervis A. J., Hanssen K. F., Henriksen T., Lorentzen B., Garg S. K., Menard M. K., Hammad S. M., Scardo J. A., Aston C. E., Lyons T. J. Trace elements as predictors of preeclampsia in type 1 diabetic pregnancy. Nutrition Research 2015;  35 (5): 421-30.

Benitez-Aguirre P. Z., Craig M. E., Cass H. G., Sugden C. J., Jenkins A., Wang J. J., Cusumano J., Hodgson L. A., Lee K., Wong T. Y., Donaghue K. C. Gender differences in retinal microvasculature through puberty in type 1 diabetes: are girls at greater risk of diabetic microvascular complications?. Investigative Ophthalmology and Visual Science 2015;  56 (1): 571-577.

Blinman Prunella, Hughes Brett, Crombie Catherine, Christmas Tim, Hudson Malcolm, Veillard Anne-Sophie, Muljadi Nick, Millward Michael, Wright Gavin, Flynn Peter, Windsor Morgan, Stockler Martin, McLachlan Sue-Anne. Patients’ and doctors’ preferences for adjuvant chemotherapy in resected non-small-cell lung cancer: What makes it worthwhile?. European Journal of Cancer 2015;  51 (12): 1529-37.

Bradstock K. F., Bilmon I., Kwan J., Micklethwaite K., Blyth E., Deren S., Bayley A., Gebski V., Gottlieb D. Single agent high dose cyclophosphamide for graft-versus-host disease prophylaxis in HLA-matched reduced intensity peripheral blood stem cell transplantation results in an unacceptably high rate of severe acute GVHD. Biology of Blood and Marrow Transplantation 2015;  21 (5): 941-4.

Brennan D. J., Hackethall A., Mann K.P., Mutz-Dehbalaie I., Fiegl H., Marth C., Obermair A. Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance. BMC Cancer 2015;  15: 33.

Brule S. Y., Jonker D. J., Karapetis C. S., O'Callaghan C. J., Moore M. J., Wong R., Tebbutt N. C., Underhill C., Yip D., Zalcberg J. R., Tu D., Goodwin R. A. Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17. European Journal of Cancer  2015;  51 (11): 1405-1414.

Burgess N. G., Pellise M., Nanda K. S., Hourigan L. F., Zanati S. A., Brown G. J., Singh R., Williams S. J., Raftopoulos S. C., Ormonde D., Moss A., Byth K., P'Ng H., McLeod D., Bourke M. J. Clinical and endoscopic predictors of cytological dysplasia or cancer in a prospective multicentre study of large sessile serrated adenomas/polyps. Gut 2015;

Chandrasegaram M. D., Chen J. W., Price T. J., Zalcberg J., Sjoquist K., Merrett N. D. Advances in molecular pathology and treatment of periampullary cancers. Pancreas 2015;

Chandrasegaram M. D., Goldstein D., Simes J., Gebski V., Kench J. G., Gill A. J., Samra J. S., Merrett N. D., Richardson A. J., Barbour A. P. Meta-analysis of radical resection rates and margin assessment in pancreatic cancer. British Journal of Surgery 2015;

Chantrill Lorraine A., Nagrial Adnan M., Watson Clare, Johns Amber L., Martyn-Smith Mona, Simpson Skye, Mead Scott, Jones Marc D., Samra Jaswinder S., Gill Anthony J., Watson Nicole, Chin Venessa T., Humphris Jeremy L., Chou Angela, Brown Belinda, Morey Adrienne, Pajic Marina, Grimmond Sean M., Chang David K., Thomas David, Sebastian Lucille, Sjoquist Katrin, Yip Sonia, Pavlakis Nick, Asghari Ray, Harvey Sandra, Grimison Peter, Simes John, Biankin Andrew V. Precision medicine for advanced pancreas cancer: the Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) trial. Clinical Cancer Research 2015;  21 (9): 2029-37.

Chia N., Fulcher J., Keech A. BANDAID. Internal Medicine Journal 2015;

Chin J., Fulcher J., Jenkins A., Keech A. Is it time to repair a fairly fast SAAB convertible? Testing an evidence-based mnemonic for the secondary prevention of cardiovascular disease. Heart, Lung & Circulation 2015;  24 (5): 480-487.

Cholesterol Treatment Trialists' (CTT) Collaboration,, Fulcher J., O'Connell R., Voysey M., Emberson J., Blackwell L., Mihaylova B., Simes J., Collins R., Kirby A., Colhoun H., Braunwald E., La Rosa J., Pedersen T. R., Tonkin A., Davis B., Sleight P., Grazia Franzosi M., Baigent C., Keech A. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials. Lancet 2015;  385 (9976): 1397-1405.

Clifton-Bligh P. B., Nery M. L., Clifton-Bligh R. J., Visvalingam S., Fulcher G. R., Byth K., Baber R. Red clover isoflavones enriched with formononetin lower serum LDL cholesterol-a randomized, double-blind, placebo-controlled study. European Journal of Clinical Nutrition 2015;  69 (1): 134-142.

Clifton-Bligh P. B., Nery M. L., Clifton-Bligh R. J., Visvalingam S., Fulcher G. R., Byth K., Baber R. Red clover isoflavones enriched with formononetin lower serum LDL cholesterol—a randomized, double-blind, placebo-controlled study. European Journal of Clinical Nutrition 2015;  69 (1): 134–142.

Davidson A., Veillard A. S., Tognela A., Chan M. M., Hughes B. G., Boyer M., Briscoe K., Begbie S., Abdi E., Crombie C., Long J., Boyce A., Lewis C. R., Varma S., Broad A., Muljadi N., Chinchen S., Espinoza D., Coskinas X., Pavlakis N., Millward M., Stockler M. R. A phase 3 randomized trial of adding topical nitroglycerin to first line chemotherapy for advanced non-small-cell lung cancer: the Australasian Lung Cancer Trials Group NITRO trial. Annals of Oncology 2015;

Davis I. D., Long A., Yip S., Espinoza D., Thompson J. F., Kichenadasse G., Harrison M., Lowenthal R. M., Pavlakis N., Azad A., Kannourakis G., Steer C., Goldstein D., Shapiro J., Harvie R., Jovanovic L., Hudson A. L., Nelson C. C., Stockler M. R., Martin A. EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first line therapy for advanced renal cell carcinoma. Annals of Oncology 2015;  26 (6): 1118-23.

Despierre E., Vergote I., Anderson R., Coens C., Katsaros D., Hirsch F.R., Boeckx B., Varella-Garcia M., Ferrero A., Ray-Coquard I., Berns E.M., Casado A., Lambrechts D., Jimeno A., European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group (EORTC-GCG), Groupe d’Investigateurs Nationaux pour les Etudes des Cancers de l’Ovaire (GINECO), Austrian Arbeitsgemeinschaft für Gynäkologische Onkologie (A-AGO), National Cancer Research Institute (NCRI), Australia New Zealand Gynaecological Oncology Group (ANZGOG), and the Mario Negri Gynecologic Oncology group (MaNGO). Epidermal growth factor receptor pathway biomarkers in the randomized phase III trial of erlotinib versus observation in ovarian cancer patients with no evidence of disease progression after first-line platinum-based chemotherapy. Targeted Oncology 2015;

Dinning P. G., Hunt L., Patton V., Zhang T., Szczesniak M., Gebski V., Jones M., Stewart P., Lubowski D. Z., Cook I. J. Treatment efficacy of sacral nerve stimulation in slow transit constipation: a two-phase, double-blind randomized controlled crossover study. American Journal of Gastroenterology 2015;  110 (5): 733-40.

Duchesne G. M., Grand M., Kron T., Haworth A., Corry J., Jackson M., Ng M., Besuijen D., Carter H. E., Martin A., Schofield D., Gebski V., Torony J., Kovacev O., Amin R., Burmeister B. Trans Tasman Radiation Oncology Group: development of the Assessment of New Radiation Oncology Technology and Treatments (ANROTAT) framework. Journal of Medical Imaging and Radiation Oncology 2015;  59 (3): 363-370.

Elmadahm A. A., Gill P. G., Bochner M., Gebski V. J., Zannino D., Wetzig N., Campbell I., Stockler M., Ung O., Simes J., Uren R. Identification of the sentinel lymph node in the SNAC-1 trial. ANZ Journal of Surgery 2015;  85 (1–2): 58–63.

Farr R. J., Januszewski A. S., Joglekar M. V., Liang H., McAulley A. K., Hewitt A. W., Thomas H. E., Loudovaris T., Kay T. W., Jenkins A., Hardikar A. A. A comparative analysis of high-throughput platforms for validation of a circulating microRNA signature in diabetic retinopathy. Scientific Reports 2015;  5: 10375.

Feletto E., Bang A., Cole-Clark D, Chalasani V., Rasiah K., Smith D.P. An examination of prostate cancer trends in Australia, England, Canada and USA: is the Australian death rate too high?. World Journal of Urology 2015;

Field K. M., Simes J., Nowak A. K., Cher L., Wheeler H., Hovey E. J., Brown C. S., Barnes E. H., Sawkins K., Livingstone A., Freilich R., Phal P. M., Fitt G., Rosenthal M. A. Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma. Neuro-oncology 2015;

Fisher O. M., Levert-Mignon A. J., Lord S. J., Botelho N. K., Freeman A. K., Thomas M. L., Falkenback D., Wettstein A., Whiteman D. C., Bobryshev Y. V., Lord R. V. High expression of cathepsin e in tissues but not blood of patients with Barrett's esophagus and adenocarcinoma. Annals of Surgical Oncology 2015;  22 (7): 2431-2438.

Fisher O. M., Levert-Mignon A. J., Lord S. J., Lee-Ng K. K., Botelho N. K., Falkenback D., Thomas M. L., Bobryshev Y. V., Whiteman D. C., Brown D. A., Breit S. N., Lord R. V. MIC-1/GDF15 in Barrett's oesophagus and oesophageal adenocarcinoma. Br J Cancer 2015;  112 (8): 1384–1391.

Francis P. A., Regan M. M., Fleming G. F., Lang I., Ciruelos E., Bellet M., Bonnefoi H. R., Climent M. A., Prada G. A., Burstein H. J., Martino S., Davidson N. E., Geyer C. E. Jr., Walley B. A., Coleman R., Kerbrat P., Buchholz S., Ingle J. N., Winer E. P., Rabaglio-Poretti M., Maibach R., Ruepp B., Giobbie-Hurder A., Price K. N., Colleoni M., Viale G., Coates A. S., Goldhirsch A., Gelber R. D. Adjuvant ovarian suppression in premenopausal breast cancer. New England Journal of Medicine 2015;  372 (5): 436-446.

Franklin J. M., Gebski V., Poston G. J., Sharma R. A. Clinical trials of interventional oncology: moving from efficacy to outcomes. Nature Reviews Clinical Oncology 2015;  12 (2): 93-104.

Garner A. A., Mann K. P., Fearnside M., Poynter E., Gebski V. The Head Injury Retrieval Trial (HIRT): a single-centre randomised controlled trial of physician prehospital management of severe blunt head injury compared with management by paramedics only. Emergency Medicine Journal 2015;

Garner A. A., Mann K. P., Poynter E., Weatherall A., Dashey S., Puntis M., Gebski V. Prehospital response model and time to CT scan in blunt trauma patients; an exploratory analysis of data from the head injury retrieval trial. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2015;  23 (1): 28.

Hafner J., Lee G., Joester J., Lynch M., Barnes E. H., Wrigley P. J., Ng K. Thermal quantitative sensory testing: a study of 101 control subjects. Journal of Clinical Neuroscience 2015;  22 (3): 588-591.

Hardikar A. A., Satoor S. N., Karandikar M. S., Joglekar M. V., Puranik A. S., Wong W., Kumar S., Limaye A., Bhat D. S., Januszewski A. S., Umrani M. R., Ranjan A. K., Apte K., Yajnik P., Bhonde R. R., Galande S., Keech A. C., Jenkins A. J., Yajnik C. S. Multigenerational undernutrition increases susceptibility to obesity and diabetes that is not reversed after dietary recuperation. Cell Metabolism 2015;

Harmer J. A., Keech A. C., Veillard A. S., Skilton M. R., Marwick T. H., Watts G. F., Meredith I. T., Celermajer D. S. Fenofibrate effects on arterial endothelial function in adults with type 2 diabetes mellitus: a FIELD substudy. Atherosclerosis 2015;  242 (1): 295-302.

Harmer J. A., Keech A. C., Veillard A. S., Skilton M. R., Marwick T. H., Watts G. F., Meredith I. T., Celermajer D. S., for the FIELD vascular study investigators. Cigarette smoking and albuminuria are associated with impaired arterial smooth muscle function in patients with type 2 diabetes mellitus: a FIELD substudy. Diabetes Research and Clinical Practice 2015;  106 (2): 328-336.

Hayne D., Stockler M., McCombie S. P., Chalasani V., Long A., Martin A., Sengupta S., Davis I. D. BCG+MMC trial: adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: a randomised phase III trial (ANZUP 1301). BMC Cancer 2015;  15 (1): 432.

Herrmann M., Sullivan D. R., Veillard A., McCorquodale T., Straub I. R., Scott R., Laakso M., Topliss D., Jenkins A. J., Blankenberg S., Burton A., Keech A. C. Serum 25-hydroxy vitamin D: a predictor of macrovascular and microvascular complications in patients with type 2 diabetes. Diabetes Care 2015;  38 (3): 521-528.

Ho M., Benitez-Aguirre P. Z., Donaghue K. C., Mitchell P., Baur L. A., Jenkins A. J., Craig M. E., Cowell C. T., Garnett S. P. Arterial elasticity in obese adolescents with clinical features of insulin resistance. Diabetes and Vascular Disease Research 2015;  12 (1): 62–69.

Horvath A. R., Bossuyt P. M., Sandberg S., St John A., Monaghan P. J., Verhagen-Kamerbeek W. D., Lennartz L., Cobbaert C. M., Ebert C., Lord S.J., for the Test Evaluation Working Group of the European Federation of Clinical Chemistry and Laboratory Medicine. Setting analytical performance specifications based on outcome studies—is it possible?. Clinical Chemistry and Laboratory Medicine 2015;  53 (6): 841–848.

Husain N., Bein K. J., Green T. C., Veillard A. S., Dinh M. M. Real time shift reporting by emergency physicians predicts overall ED performance. Emergency Medicine Journal 2015;  32 (2): 130–133.

Husain N., Bein K. J., Green T. C., Veillard A. S., Dinh M. M. Real time shift reporting by emergency physicians predicts overall ED performance. Emergency Medicine Journal 2015;  32 (2): 130–133.

Jenkins A. The world I want—a world with less diabetes. Medical Journal of Australia 2015;  202 (2): 108–109.

Juraskova I., Butow P., Fisher A., Bonner C., Anderson C., Bu S., Scarlet J., Stockler M. R., Wetzig N., Ung O., Campbell I. Development and piloting of a decision aid for women considering participation in the Sentinel Node Biopsy versus Axillary Clearance 2 breast cancer trial. Clinical Trials 2015;  12 (4): 409-17.

Juraskova I., Butow P., Fisher A., Bonner C., Anderson C., Bu S., Scarlet J., Stockler M. R., Wetzig N., Ung O., Campbell I. Development and piloting of a decision aid for women considering participation in the Sentinel Node Biopsy versus Axillary Clearance 2 breast cancer trial. Clinical Trials 2015;  12 (4): 409-417.

Kaltoft M. K., Turner R., Cunich M., Salkeld G., Nielsen J. B., Dowie J. Addressing preference heterogeneity in public health policy by combining cluster analysis and multi-criteria decision analysis: proof of method. Health Economics Review 2015;  5: 10.

Khemka A., Frossard L., Lord S. J., Bosley B., Al Muderis M. Osseointegrated total knee replacement connected to a lower limb prosthesis: 4 cases. Acta Orthopaedica 2015; : 1-5.

Khemka A., Lord S. J., Doyle Z., Bosley B., Al Muderis M. Minimally invasive medial patellofemoral ligament reconstruction for patellar instability using an artificial ligament: a two year follow-up. Knee 2015;

Labra J., Menon P., Byth K., Morrison S., Vucic S. Rate of disease progression: a prognostic biomarker in ALS. Journal of Neurology, Neurosurgery and Psychiatry 2015;

Lam J., Lord S. J., Hunter K. E., Simes R. J., Vu T., Askie L. M. Australian clinical trial activity and burden of disease: an analysis of registered trials in National Health Priority Areas. Medical Journal of Australia 2015;  203 (2): 97-101.

Lee C. K., Goldstein D., Gibbs E., Joensuu H., Zalcberg J., Verweij J., Casali P. G., Maki R. G., Cioffi A., McArthur G., Lord S. J., Yip D., Kanjanapan Y., Rutkowski P. Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinib. European Journal of Cancer 2015;  51 (7): 852-60.

Lee C. K., Lord S., Grunewald T., Gebski V., Hardy-Bessard A. C., Sehouli J., Woie K., Heywood M., Schauer C., Vergote I., Scambia G., Ferrero A., Harter P., Pujade-Lauraine E., Friedlander M. Impact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: analysis of the CALYPSO trial. Gynecologic Oncology 2015;  136 (1): 18–24.

Lee Chee Khoon, Wu Yi-Long, Ding Pei Ni, Lord Sarah J., Inoue Akira, Zhou Caicun, Mitsudomi Tetsuya, Rosell Rafael, Pavlakis Nick, Links Matthew, Gebski Val, Gralla Richard J., Yang James Chih-Hsin. Impact of specific epidermal growth factor receptor (EGFR) mutations and clinical characteristics on outcomes after treatment with EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR-mutant lung cancer: a meta-analysis. Journal of Clinical Oncology 2015;  33 (17): 1958-65.

Leong T., Smithers B. M., Michael M., Gebski V., Boussoutias A., Miller D., Simes J., Zalcberg J., Hausterman K., Lordick F., Schuhmacher C., Swallow C., Darling G., Wong R. TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG). BMC Cancer 2015;  15: 532.

Ling N., Martin A. Three suturing techniques for closing fusiform excisions. A randomised controlled study. Australasian Journal of Dermatology 2015;

Liu J., Zhang M., Rose B., Veillard A. S., Jones D., Zhang X., Soon Lee C., Milross C., Hong A. Ki67 expression has prognostic significance in relation to human papillomavirus status in oropharyngeal squamous cell carcinoma. Annals of Surgical Oncology 2015;  22 (6): 1893-1900.

Loh S. F., Cooper C., Selinger C. I., Barnes E. H., Chan C., Carmalt H., West R., Gluch L., Beith J. M., Caldon C. E., O'Toole S. Cell cycle marker expression in benign and malignant intraductal papillary lesions of the breast. Journal of Clinical Pathology 2015;  68 (3): 187-191.

Lyerly H. K., Fawzy M. R., Aziz Z., Nair R., Pramesh C. S., Parmar V., Parikh P. M., Jamal R., Irumnaz A., Ren J., Stockler M. R., Abernethy A. P. Regional variation in identified cancer care needs of early-career oncologists in China, India, and Pakistan. Oncologist 2015;  20 (5): 532-8.

Mahner S., Meier W., Du Bois A., Brown C., Lorusso D., Dell'Anna T., Cretin J., Havsteen H., Bessette P., Zeimet A. G., Vergote I., Vasey P., Pujade-Lauraine E., Gladieff L., Ferrero A. Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial. European Journal of Cancer 2015;  51 (3): 352-358.

Mann K., Power E., Barnes S., Togher L. Questioning in conversations before and after communication partner training for individuals with traumatic brain injury. Aphasiology 2015;  29 (9): 1082-1109.

McGowan E. M., Simpson A., McManaman J., Boonyaratanakornkit V., Hardikar A. A. Hijacking of endocrine and metabolic regulation in cancer and diabetes. BioMed Research International 2015; : 386203.

Moher D., Shamseer L., Clarke M., Ghersi D., Liberati A., Petticrew M., Shekelle P., Stewart L. A. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic Reviews 2015;  4 (1): 1.

Murray S. R., Murchie P., Campbell N., Walter F. M., Mazza D., Habgood E., Kutzer Y., Martin A., Goodall S., Barnes D. J., Emery J. D. Protocol for the CHEST Australia trial: a phase II randomised controlled trial of an intervention to reduce time-to-consult with symptoms of lung cancer. BMJ Open 2015;  5 (5): e008046.

Nestel P., Clifton P., Colquhoun D., Noakes M., Mori T. A., Sullivan D., Thomas B. Indications for omega-3 long chain polyunsaturated fatty acid in the prevention and treatment of cardiovascular disease. Heart, Lung & Circulation 2015;

Nguyen H. T., Lim W. H., Craig J. C., Chapman J. R., Lord S. J., Howard K., Wong G. The relative benefits and costs of solid phase bead technology to detect preformed donor specific antihuman leukocyte antigen antibodies in determining suitability for kidney transplantation. Transplantation 2015;  99 (5): 957-964.

Ong K. L., Januszewski A. S., O'Connell R., Jenkins A. J., Xu A., Sullivan D. R., Barter P. J., Hung W. T., Scott R. S., Taskinen M. R., Keech A. C., Rye K. A. The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study. Diabetologia 2015;  58 (3): 464-473.

Pollock S., O'Brien R., Makhija K., Hegi-Johnson F., Ludbrook J., Rezo A., Tse R., Eade T., Yeghiaian-Alvandi R., Gebski V., Keall P. J. Audiovisual biofeedback breathing guidance for lung cancer patients receiving radiotherapy: a multi-institutional phase II randomised clinical trial. BMC Cancer 2015;  15 (1): 526.

Pollock S., O'Brien R., Makhija K., Hegi-Johnson F., Ludbrook J., Rezo A., Tse R., Eade T., Yeghiaian-Alvandi R., Gebski V., Keall P. J. Audiovisual biofeedback breathing guidance for lung cancer patients receiving radiotherapy: a multi-institutional phase II randomised clinical trial. Bmc Cancer 2015;  15

Price T. J., Bruhn M. A., Lee C. K., Hardingham J. E., Townsend A. R., Mann K. P., Simes J., Weickhardt A., Wrin J. W., Wilson K., Gebski V., Van Hazel G., Robinson B., Cunningham D., Tebbutt N. C. Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancer. British Journal of Cancer 2015;  112: 963-970.

Ramanathan S., Prelog K., Barnes E. H., Tantsis E. M., Reddel S. W., Henderson A. P., Vucic S., Gorman M. P., Benson L. A., Alper G., Riney C. J., Barnett M., Parratt J., Hardy T. A., Leventer R. J., Merheb V., Nosadini M., Fung V. S., Brilot F., Dale R. C. Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis. Multiple Sclerosis 2015;

Roohullah A., Wong H.L. Sjoquist K.M., Gibbs P., FIeld K., Tran B., Shapiro J., McKendrick J., Yip D., Nott L., Gebski V., Ng W., Chua W., Price T., Tebbutt N., Chantrill L. Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab. World Journal of Gastroenterology 2015;  21 (17): 5352-5358.

Sabeti F., Nolan C. J., James A. C., Jenkins A., Maddess T. Multifocal pupillography identifies changes in visual sensitivity according to severity of diabetic retinopathy in type 2 diabetes. Investigative Ophthalmology & Visual Science 2015;  56 (8): 4504-4513.

Sandhu S., Petsoglou C., Grigg J., Veillard A. S. Elevated intraocular pressure in patients undergoing penetrating keratoplasty and descemet stripping endothelial keratoplasty. Journal of Glaucoma 2015;

Schofield D. J., Callander E. J., Shrestha R. N., Passey M. E., Kelly S. J., Percival R. Back problems, comorbidities, and their association with wealth. Spine Journal 2015;  15 (1): 34–41.

Schofield D. J., Callander E. J., Shrestha R. N., Passey M. E., Kelly S. J., Percival R. Back problems, co-morbidities and their association with wealth. Spine Journal 2015;  15 (1): 34-41.

Schofield D. J., Callander E. J., Shrestha R. N., Percival R., Kelly S. J., Passey M. E. Labour force participation and the influence of having arthritis on financial status. Rheumatology International 2015;  35 (7): 1175-81.

Schofield D., Cunich M., Kelly S., Passey M. E., Shrestha R., Callander E., Tanton R., Veerman L. The impact of diabetes on the labour force participation, savings and retirement income of workers aged 45–64 years in Australia. PLOS One 2015;  10 (2): e0116860.

Schofield D.J., Callander E.J., Shrestha R.N., Passey M.E., Kelly S.J., Percival R. Multiple chronic health conditions and their link with wealth assets. European Journal of Public Health 2015;  25 (2): 285-9.

Schofield Penelope E., Stockler M. R., Zannino D., Tebbutt N. C., Price T. J., Simes R. J., Wong N., Pavlakis N., Ransom D., Moylan E., Underhill C., Wyld D., Burns I., Ward R., Wilcken N., Jefford M. Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer. Supportive Care in Cancer 2015;

Schou I. M., Marschner I.C. Methods for exploring treatment effect heterogeneity in subgroup analysis: an application to global clinical trials. Pharmaceutical Statistics 2015;  14 (1): 44–55.

Schulson M., Liu A., Bjorkman T., Quinton A., Mann K. P., Benzie R., Peek M., Nanan R. Mid-gestational enlargement of fetal thalami in women exposed to methadone during pregnancy. Frontiers in Surgery 2015;  1: 28.

Scott K.M., Caldwell P.H.Y., Barnes E.H., Barrett J. “Teaching by humiliation” and mistreatment of medical students in clinical rotations: a pilot study. Medical Journal of Australia 2015;  203 (4): 185.

Seimon R. V., Espinoza D., Finer N., James W. P., Legler U. F., Coutinho W., Sharma A. M., Van Gaal L., Maggioni A. P., Sweeting A., Torp-Pedersen C., Gebski V., Caterson I. D. Changes in body weight and pulse: outcome events in overweight and obese subjects with cardiovascular disease in the SCOUT trial. International Journal of Obesity 2015;  39 (5): 849-57.

Sengupta S., Grimison P., Hayne D., Williams S., Chambers S., de Souza P., Stockler M., McJannett M., Toner G., Davis I. D. ANZUP—a new co-operative cancer trials group in genito-urinary oncology. BJU International 2015;  115 (6): 856-858.

Sjoquist K. M., Zalcberg J. R. Gastric cancer: past progress and present challenges. Gastric Cancer 2015;  18 (2): 205-209.

Soll R. F., Tarnow-Mordi W. O. Optimizing placental transfusion for preterm infants. Pediatrics 2015;  136 (1): 177-179.

Stitt A. W., Curtis T. M., Chen M., Medina R. J., McKay G. J., Jenkins A., Gardiner T. A., Lyons T. J., Hammes H. P., Simo R., Lois N. The progress in understanding and treatment of diabetic retinopathy. Progress in Retinal and Eye Research 2015;

Sullivan D. R., Watts G. F., Nicholls S. J., Barter P., Grenfell R., Chow C. K., Tonkin A., Keech A. Clinical guidelines on hyperlipidaemia: Recent developments, future challenges and the need for an Australian REVIEW. Heart, Lung & Circulation 2015;  24 (5): 495-502.

Sundaresan P., King M. T., Stockler M. R., Costa D. S., Milross C. G. Barriers to radiotherapy utilisation in New South Wales Australia: Health professionals' perceptions of impacting factors. Journal of Medical Imaging and Radiation Oncology 2015;  59 (4): 535-41.

Sundaresan P., Sullivan L., Pendlebury S., Kirby A., Rodger A., Joseph D., Campbell I., Dhillon H. M., Stockler M. R. Patients' perceptions of health-related quality of life during and after adjuvant radiotherapy for T1N0M0 breast cancer. Clinical Oncology 2015;  27 (1): 9–15.

Swerdlow Daniel I., Preiss David, Kuchenbaecker Karoline B., Holmes Michael V., Engmann Jorgen E. L., Shah Tina, Sofat Reecha, Stender Stefan, Johnson Paul C. D., Scott Robert A., Leusink Maarten, Verweij Niek, Sharp Stephen J., Guo Yiran, Giambartolomei Claudia, Chung Christina, Peasey Anne, Amuzu Antoinette, Li KaWah, Palmen Jutta, Howard Philip, Cooper Jackie A., Drenos Fotios, Li Yun R., Lowe Gordon, Gallacher John, Stewart Marlene C. W., Tzoulaki Ioanna, Buxbaum Sarah G., van der A Daphne L., Forouhi Nita G., Onland-Moret N. Charlotte, van der Schouw Yvonne T., Schnabel Renate B., Hubacek Jaroslav A., Kubinova Ruzena, Baceviciene Migle, Tamosiunas Abdonas, Pajak Andrzej, Topor-Madry Romanvan, Stepaniak Urszula, Malyutina Sofia, Baldassarre Damiano, Sennblad Bengt, Tremoli Elena, de Faire Ulf, Veglia Fabrizio, Ford Ian, Jukema J. Wouter, Westendorp Rudi G. J., de Borst Gert Jan, de Jong Pim A., Algra Ale, Spiering Wilko, der Zee Anke H. Maitland-van, Klungel Olaf H., de Boer Anthonius, Doevendans Pieter A., Eaton Charles B., Robinson Jennifer G., Duggan David, Kjekshus John, Downs John R., Gotto Antonio M., Keech Anthony C., Marchioli Roberto, Tognoni Gianni, Sever Peter S., Poulter Neil R., Waters David D., Pedersen Terje R., Amarenco Pierre, Nakamura Haruo, McMurray John J. V., Lewsey James D., Chasman Daniel I., Ridker Paul M., Maggioni Aldo P., Tavazzi Luigi, Ray Kausik K., Seshasai Sreenivasa Rao Kondapally, Manson JoAnn E., Price Jackie F., Whincup Peter H., Morris Richard W., Lawlor Debbie A., Smith George Davey, Ben-Shlomo Yoav, Schreiner Pamela J., Fornage Myriam, Siscovick David S., Cushman Mary, Kumari Meena, Wareham Nick J., Verschuren W. M. Monique, Redline Susan, Patel Sanjay R., Whittaker John C., Hamsten Anders, Delaney Joseph A., Dale Caroline, Gaunt Tom R., Wong Andrew, Kuh Diana, Hardy Rebecca, Kathiresan Sekar, Castillo Berta A., van der Harst Pim, Brunner Eric J., Tybjaerg-Hansen Anne, Marmot Michael G., Krauss Ronald M., Tsai Michael, Coresh Josef, Hoogeveen Ronald C., Psaty Bruce M., Lange Leslie A., Hakonarson Hakon, Dudbridge Frank, Humphries Steve E., Talmud Philippa J., Kivimäki Mika, Timpson Nicholas J., Langenberg Claudia, Asselbergs Folkert W., Voevoda Mikhail, Bobak Martin, Pikhart Hynek, Wilson James G., Reiner Alex P., Keating Brendan J., Hingorani Aroon D., Sattar Naveed. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials. Lancet 2015;  385 (9965): 351–361.

Tarnow-Mordi W. O. Reply [letter]. American Journal of Obstetrics and Gynecology 2015;

Thanh Pham T., Cross S., Gebski V., Veness M. J. Squamous cell carcinoma of the lip in Australian patients: definitive radiotherapy is an efficacious option to surgery in select patients. Dermatologic Surgery 2015;  41 (2): 219-25.

Tierney J. F., Pignon J. P., Gueffyier F., Clarke M., Askie L., Vale C. L., Burdett S., Cochrane IPD Meta-analysis Methods Group. How individual participant data meta-analyses have influenced trial design, conduct, and analysis. Journal of Clinical Epidemiology 2015;

Tonkin Andrew M., Blankenberg Stefan, Kirby Adrienne, Zeller Tanja, Colquhoun David M., Funke-Kaiser Anne, Hague Wendy, Hunt David, Keech Anthony C., Nestel Paul, Stewart Ralph, Sullivan David R., Thompson Peter L., West Malcolm, White Harvey D., Simes John. Biomarkers in stable coronary heart disease, their modulation and cardiovascular risk: the LIPID biomarker study. International Journal of Cardiology 2015;  201: 499–507.

Tully P. J., Baumeister H., Bengel J., Jenkins A., Januszewski A., Martin S., Wittert G. A. The longitudinal association between inflammation and incident depressive symptoms in men: the effects of hs-CRP are independent of abdominal obesity and metabolic disturbances. Physiology and Behavior 2015;  139: 328–335.

Veerman J. L., Shrestha R. N., Mihalopoulos C., Passey M. E., Kelly S. J., Tanton R., Callander E. J., Schofield D. J. Depression prevention, labour force participation and income of older working aged Australians: a microsimulation economic analysis. Australian and New Zealand Journal of Psychiatry 2015;  49 (5): 430-436.

Waldman B., Jenkins A. J., Sullivan D., Ng M. K., Keech A. C. HDL as a target for glycemic control. Current Drug Targets 2015;

Walker R. C., Howard K., Morton R. L., Palmer S. C., Marshall M. R., Tong A. Patient and caregiver values, beliefs and experiences when considering home dialysis as a treatment option: a semi-structured interview study. Nephrology, Dialysis, Transplantation 2015;

Weickhardt A. J., Williams D. S., Lee C. K., Chionh F., Simes J., Murone C., Wilson K., Parry M. M., Asadi K., Scott A. M., Punt C. J., Nagtegaal I. D., Price T. J., Mariadason J. M., Tebbutt N. C. Vascular endothelial growth factor D expression is a potential biomarker of bevacizumab benefit in colorectal cancer. British Journal of Cancer 2015;

Wetzig N., Gill P. G., Zannino D., Stockler M. R., Gebski V., Ung O., Campbell I., Simes R. J. Sentinel lymph node based management or routine axillary clearance? three-year outcomes of the RACS Sentinel Node Biopsy Versus Axillary Clearance (SNAC) 1 trial. Annals of Surgical Oncology 2015;  22 (1): 17–23.

Whiteman D. C., Appleyard M., Bahin F. F., Bobryshev Y. V., Bourke M. J., Brown I., Chung A., Clouston A., Dickins E., Emery J., Eslick G. D., Gordon L. G., Grimpen F., Hebbard G., Holliday L., Hourigan L., Kendall B. J., Lee E. Y., Levert A., Lord R. V., Lord S. J., Maule D., Moss A., Norton I., Olver I., Pavey D., Raftopoulos S., Rajendra S., Schoeman M., Singh R., Sitas F., Smithers B. M., Taylor A., Thomas M. L., Thomson I., To H., von Dincklage J., Vuletich C., Watson D. I., Yusoff I. F. Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma. Journal of Gastroenterology and Hepatology 2015;  30 (5): 804-20.

Wilkinson Dominic, Chalmers Iain, Cruz Melinda, Tarnow-Mordi William. Dealing with the unknown: reducing the proportion of unvalidated treatments offered to children [editorial]. Archives of Disease in Childhood Fetal and Neonatal Edition 2015;  100 (3): F190-F192.

Williams K. H., Vieira De Ribeiro A. J., Prakoso E., Veillard A. S., Shackel N. A., Brooks B., Bu Y., Cavanagh E., Raleigh J., McLennan S. V., McCaughan G. W., Keane F. M., Zekry A., Gorrell M. D., Twigg S. M. Circulating dipeptidyl peptidase-4 activity correlates with measures of hepatocyte apoptosis and fibrosis in non-alcoholic fatty liver disease in type 2 diabetes mellitus and obesity: A dual cohort cross-sectional study. Journal of Diabetes 2015;

Williams K. H., Viera de Ribeiro A. J., Prakoso E., Veillard A. S., Shackel N. A., Bu Y., Brooks B., Cavanagh E., Raleigh J., McLennan S. V., McCaughan G. W., Bachovchin W. W., Keane F. M., Zekry A., Twigg S. M., Gorrell M. D. Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesity. Diabetes Research and Clinical Practice 2015;  108 (3): 466-72.

Wong W., Farr R., Joglekar M., Januszewski A., Hardikar A. Probe-based real-time PCR approaches for quantitative measurement of microRNAs. Journal of Visualized Experiments: JoVE 2015; (98)

Zagora S. L., Funnell C. L., Martin F. J., Smith J. E., Hing S., Billson F. A., Veillard A. S., Jamieson R. V., Grigg J. R. Primary congenital glaucoma outcomes: lessons from 23 years of follow-up. American Journal of Ophthalmology 2015;  159 (4): 788-96.